NCT03017703View on ClinicalTrials.gov

The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

October 1, 2019

Study Completion Date

December 15, 2019

Conditions
Endothelial DysfunctionInsulin Resistance
Interventions
DRUG

Eplerenone

Trial Locations (1)

5000

Cardiovascular and Renal Research, Odense

All Listed Sponsors
lead

University of Southern Denmark

OTHER

NCT03017703 - The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes | Biotech Hunter | Biotech Hunter